Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes

Francis J. Giles, Hagop M. Kantarjian, Jorge E. Cortes, Stephan Faderl, Srdan Verstovsek, Deborah Thomas, Guillermo Garcia-Manero, William Wierda, Alessandra Ferrajoli, Stephen Kornblau, Gloria N. Mattiuzzi, Apostolia M. Tsimberidou, Maher Albitar, Susan M. O'Brien, Elihu Estey

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences